Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Medical Teacher|November 18, 2014
How we used a patient visit tracker tool to advance experiential learning in systems-based practice and quality improvement in a medical student clinicChen Amy Chen, Ryan J Park, John V Hegde, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2017
A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipientsCarolyn D Alonso, David A Braun, Ishan Patel, et al.
The Oncologist|April 19, 2022
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial CarcinomaTomi Jun, Noah M Hahn, Guru Sonpavde, et al.
Plos One|August 19, 2022
Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experienceSunny Guin, Bobby K Liaw, Tomi Jun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid TumorsYoonha Choi, Neekesh V Dharia, Tomi Jun, et al.
Frontiers in Medicine|March 17, 2022
Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 PatientsShilong Li, Tomi Jun, Jonathan Tyler, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2022
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumorsGeorge Mellgard, Vaibhav G Patel, Xiaobo Zhong, et al.
Thrombosis Research|August 28, 2020
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, et al.
Hepatology Communications|April 13, 2019
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C InfectionTomi Jun, Yao-Chun Hsu, Shintaro Ogawa, et al.
Discover Oncology|August 12, 2022
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Tomi Jun, Bo Wang, et al.
Pageof 5